Dabigatran versus Warfarin for Acute Venous Thromboembolism


Dabigatran versus Warfarin for Acute Venous Thromboembolism
Slides from a presentation at ASH 2011 and transcribed comments from a recent interview with Kenneth A Bauer, MD (1/26/12)

Schulman S et al. A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II). Proc ASH 2011;Abstract 205.

Dr Bauer is Professor of Medicine at Harvard Medical School, Chief of the Hematology Section of the VA Boston Healthcare System and Director of Thrombosis Clinical Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts.